Care You Can Count On
Bionote is an animal health diagnostics company that provides in-clinic, quantitative tests to enhance a veterinarian’s capabilities in their point-of-care lab. Founded in South Korea by Dr. YS Cho, Bionote expanded to the U.S. in 2019 and has improved patient care with over 17,000 units sold worldwide.
Our testing machines are affordable, easy-to-use and provide accurate quantitative results in minutes through state-of-the-art europium technology. Analyzers using europium-detection technology allow for greater separation in measuring wavelengths of general fluorescence, decreasing overlap and increasing accuracy. We work with doctors who regularly perform studies to validate the accuracy of these tests and prioritize hiring people with a strong veterinary background to move the company forward.
As we continue to expand with new tests and different markets, our goal stays the same: Give veterinarians the tools they need for the best possible standard of care.
Bionote Korea launches Vcheck series, an Immunofluorescence Analyzer for Veterinary use
Cumulative Global Vcheck Sales Reach Surpasses 11,000 units (#1 Best-Selling Fluorescent Immunoassay Analyzer)
Canine and Feline Troponin are added to Bionote USA Vcheck line (Becomes the only manufacturer in the veterinary marketplace to offer fully-quantitative Troponin I for both species)
Bionote USA introduces molecular diagnostics to the marketplace (Vcheck M)
Bionote USA was established
Feline NT-proBNP is added to Bionote USA’s NT-proBNP line (Becomes the only manufacturer in the veterinary marketplace to offer in-clinic, fully-quantitative NT-proBNP for both species)
Bionote USA launches Vcheck Equine products (Progesterone, SAA and IgG)